I now have comprehensive information. Let me compile the answer.
BP 150/115 mmHg — Classification & Treatment
Classification
A BP of
150/115 mmHg is
Stage 2 Hypertension (SBP ≥140 mmHg
or DBP ≥90 mmHg) by both the 2017 ACC/AHA and the updated
2025 ACC/AHA guidelines. The diastolic of 115 mmHg also warrants particular attention, as isolated or predominant diastolic elevation can indicate secondary hypertension and signals higher near-term risk.
Step 1 — Rule Out Hypertensive Emergency
Before starting outpatient treatment, determine if there is end-organ damage:
| Feature | Urgency vs. Emergency |
|---|
| BP >180/120 with no symptoms or organ damage | Severe hypertension (formerly "urgency") — oral agents, not IV |
| Headache, chest pain, dyspnea, visual changes, AMS, focal neuro signs | Hypertensive emergency — IV agents, ICU |
| Fundoscopy: papilledema, flame hemorrhages | Emergency |
| Elevated creatinine, proteinuria, ACS on ECG | Emergency |
At 150/115, this is likely uncomplicated stage 2 hypertension, but screen for symptoms and check urinalysis, creatinine, ECG, and fundoscopy on first visit.
Step 2 — Lifestyle Modifications (Nonpharmacologic)
Required for all patients, in parallel with drug therapy at this level:
- Sodium restriction: <2,300 mg/day (ideally <1,500 mg/day)
- Weight loss: Even 5% reduction lowers BP meaningfully
- DASH diet: Rich in fruits, vegetables, low-fat dairy
- Aerobic exercise: ≥150 min/week moderate intensity
- Limit alcohol: ≤2 drinks/day (men), ≤1 (women)
- Stop smoking
(Harrison's 22E, Prevention and Treatment of Primary Hypertension)
Step 3 — Antihypertensive Drug Therapy
Per the 2025 ACC/AHA guidelines and Harrison's 22E, Stage 2 HTN requires combination therapy from the outset — do not start with a single agent and wait.
First-Line Drug Classes (Evidence-Based)
| Class | Example Drugs | Notes |
|---|
| Thiazide / thiazide-like diuretic | Chlorthalidone 12.5–25 mg, HCTZ 25 mg | Preferred thiazide-like agent is chlorthalidone |
| ACE Inhibitor (ACEi) | Lisinopril 10–40 mg, Ramipril 5–10 mg | Avoid in bilateral renal artery stenosis; contraindicated in pregnancy |
| Angiotensin Receptor Blocker (ARB) | Losartan, Valsartan, Olmesartan | Use if ACEi not tolerated (e.g., cough) |
| Dihydropyridine Calcium Channel Blocker (CCB) | Amlodipine 5–10 mg | Effective; combine well with ACEi/ARB |
"Most patients with hypertension require treatment with more than one antihypertensive agent. This is especially the case for adults with stage 2 hypertension with an SBP ≥140 mmHg."
— Harrison's Principles of Internal Medicine 22E
Recommended Starting Strategy for 150/115
-
Start 2 drugs simultaneously — preferred as a single-pill combination (SPC) to improve adherence.
- Common combos: ACEi + CCB (e.g., perindopril/amlodipine) or ARB + thiazide
- The 2025 guidelines explicitly recommend starting 2 first-line agents for Stage 2 HTN
-
BP goal: <130/80 mmHg for all adults (2025 ACC/AHA)
-
Reassess in 1 month — titrate doses or add a third agent if goal not reached
Special Populations (Preferred Agents)
| Comorbidity | Preferred |
|---|
| CKD or proteinuria (ACR >30 mg/g) | ACEi or ARB |
| Diabetes | ACEi or ARB |
| Heart failure with reduced EF | ACEi/ARB + beta-blocker + spironolactone |
| Post-MI | Beta-blocker + ACEi |
| Pregnancy | Labetalol or extended-release nifedipine |
| Black patients (non-Hispanic) | Thiazide + CCB (ACEi/ARB less effective as monotherapy) |
When to Refer / Investigate for Secondary Causes
Consider secondary hypertension (especially with high diastolic) if:
- Age <40, resistant to 3 drugs, hypokalemia (primary aldosteronism), episodic symptoms (pheochromocytoma), or renal bruit
Bottom line: 150/115 is Stage 2 HTN. Start lifestyle changes + two first-line drugs (e.g., ACEi/ARB + CCB or thiazide as a single-pill combo), target BP <130/80, and reassess in 4 weeks. Urgently rule out end-organ damage before initiating outpatient therapy.